Ipamorelin 50 min read January 28, 2026

Tesamorelin vs Ipamorelin

Tesamorelin and Ipamorelin are both peptide-based therapeutics that belong to the class of growth hormone-releasing peptides (GHRPs). They are used for different purposes and have distinct receptor binding properties, but because they both affect natural growth hormone (GH) levels, they have similar effects in many respects. Both peptides have seen renewed research interest, however, thanks to a boom in the weight loss field led by peptide compounds like semaglutide and liraglutide. While both Tesamorelin and Ipamorelin are associated with changes in body composition, fat mass, and lean body mass, there is a great deal more to what these peptides can do.

Tesamorelin vs. Ipamorelin: Properties

Tesamorelin is approved for the treatment of HIV-associated lipodystrophy. This very narrow approval belies the peptide's wider use as an agent for altering body composition. Research indicates that Tesamorelin can reduce fat mass, boost muscle and bone mass, improve peripheral nerve regeneration, and may even be useful in the treatment of mild cognitive impairment.

Ipamorelin, which underwent phase II clinical trials for the treatment of postoperative ileus, is known to be the most selective ghrelin receptor (aka growth hormone secretagogue receptor/GHSR) agonist yet discovered. It increases plasma growth hormone levels in animals but has no effect on prolactin, follicle-stimulating hormone, luteinizing hormone, thyroid-stimulating hormone, or adrenocorticotropic hormone levels. The astounding specificity of Ipamorelin makes it a highly useful peptide for studying the effects of increased GH levels with confounding results by elevating levels of other hormones.

Tesamorelin vs Ipamorelin: Mechanism of Action

What is so interesting about these two peptides is the fact that they both raise GH levels by binding to different receptors. Ipamorelin works by binding to and activating the ghrelin receptor, which is located in the brain and the pituitary gland. Activation of this receptor leads to an increase in GH release. It does not interact directly with the growth hormone-releasing hormone (GHRH) receptor like some other GHRPs.

Tesamorelin acts as a synthetic analog of human GHRH, which is a hormone that stimulates the release of GH from the pituitary gland. By binding to the GHRH receptor, Tesamorelin activates the receptor, leading to a cascade of intracellular signaling events. This results in an increase in the synthesis and secretion of growth hormone. Tesamorelin promotes the release of growth hormone in a pulsatile manner, similar to the body's natural pattern of GH secretion. This pulsatile release is important for maintaining the normal physiological functions associated with growth hormone.

Growth hormone stimulates the liver and other tissues to produce insulin-like growth factor-1 (IGF-1). Both Tesamorelin and Ipamorelin's action of increasing growth hormone levels consequently leads to an increase in IGF-1 levels. Ipamorelin has a relatively short duration of action and leads to temporary but large increases in GH and IGF-1 levels. Tesamorelin also has a relatively short duration of action. For both peptides, levels of GH and IGF-1 return to baseline after just a few hours. Tesamorelin, which is administered once daily, has a slightly greater effect on GH levels. Ipamorelin is generally considered to have a more moderate and controlled effect, mimicking the body's natural pattern of secretion. Both peptides preserve the body's natural pulsatile release of GH, a factor that is associated with a lower risk of desensitization and unwanted effects compared to continuous stimulation of GH release.

Tesamorelin vs Ipamorelin: Fat Loss

The most obvious comparison to make between Tesamorelin and Ipamorelin is in the ability of these two peptides to promote fat loss and alter body composition. While Tesamorelin is specifically approved for the reduction of adiposity, both peptides are relatively similar in their stimulation of GH release and should therefore produce somewhat similar results on body composition. Here is what the science says.

Tesamorelin has been shown to reduce adiposity by approximately 20% in a year[1]. It is known to be particularly effective in reducing visceral fat. Visceral fat is the fat that wraps around abdominal organs and is different from the subcutaneous fat that sits below the skin. A little bit of visceral fat is good for protecting organs, but too much of it can lead to dangerous health consequences including high levels of lipids and triglycerides in the bloodstream. In fact, research shows that administration of Tesamorelin can reduce triglyceride levels by approximately 25% over just 26 weeks. This may not seem like a lot, but it is similar to other common "cholesterol" drugs like niacin, atorvastatin, and simvastatin.

Tesamorelin has been shown to have positive effects on muscle mass, although its primary indication is for reducing excess abdominal fat in individuals with HIV-associated lipodystrophy. While most clinical studies of Tesamorelin have focused on its effects on reducing visceral adipose tissue (VAT) or abdominal fat, some studies have reported secondary improvements in body composition, including an increase in lean body mass or muscle mass. Combining Tesamorelin treatment with regular exercise, particularly resistance training, may have synergistic effects on muscle growth and maintenance. Exercise can further stimulate protein synthesis and enhance the anabolic response to Tesamorelin.

Research in mice shows that Ipamorelin can significantly increase growth hormone (GH) levels, with reported increases ranging from 3-fold to 13-fold above baseline levels. The impact of increased GH levels resulting from Ipamorelin administration on body composition has been studied in animal models. Studies suggest that if the diet is kept consistent, Ipamorelin treatment can lead to an increase of approximately 9% in muscle mass and a decrease of around 14% in fat mass, even without changes in exercise volume[2], [3].

The effects of Ipamorelin on triglyceride levels have not been extensively studied in human clinical trials. Therefore, the specific impact of Ipamorelin on triglyceride levels in humans is not well-established. However, as Ipamorelin stimulates the release of growth hormone (GH), it is important to note that GH can have potential effects on lipid metabolism, including triglyceride levels. GH has been shown to increase lipolysis (breakdown of fat) and improve lipid profiles in some individuals. In animal studies, Ipamorelin has been shown to reduce fat mass, which could potentially have an indirect effect on triglyceride levels.

Tesamorelin vs Ipamorelin: Fat Quality

It may sound odd to talk about the quality of fat, but research has revealed over the last several decades that all adipose tissue is not created the same. While there has been a great deal of emphasis on fat quantity from mainstream sources, there has been decidedly less discussion about fat quality and why it matters.

Adipose tissue (AT) is not just a passive energy storage depot but is increasingly being recognized as an active endocrine and inflammatory organ. In fact, thinking of adipose tissue as "fat" isn't entirely accurate. It consists of adipocytes (fat cells), connective tissue, nerves, blood vessels, and immune cells, all working together as a single unit. AT responds to hormonal and neuronal signals and plays a crucial role in maintaining metabolic homeostasis.

One of the ways AT exerts its effects on the body is through the secretion of various factors, including leptin and adiponectin. These factors, along with others, regulate metabolic processes and influence overall metabolic health. Research has primarily focused on the quantity of two types of AT: visceral adipose tissue (VAT), which surrounds internal organs, and subcutaneous adipose tissue (SAT), which is located just beneath the skin. It was originally assumed that changes in AT quantity are directly related to changes in AT quality or function. It was similarly assumed that SAT and VAT tissue were generally the same.

Careful observation has revealed that the above assumptions cannot be accurate. For instance, it has been observed that increases in AT quantity, such as in cases of metabolically healthy obesity, are not always accompanied by obvious cardiometabolic consequences. Similarly, AT quality can vary even at the same AT quantity, suggesting that AT quality may independently contribute to metabolic health. Evaluating AT quality is typically done through computed tomography (CT) scanning, where denser AT is associated with smaller, better-quality adipocytes, while lower density indicates larger, more lipid-engorged, poorer quality adipocytes.

Observational studies in the general population, such as the Framingham Heart Study, have indicated that lower VAT and SAT density are associated with lower levels of adiponectin (a beneficial adipokine) and increased cardiovascular disease risk. So, what is low-quality fat? Basically, low-quality fat is fat that is made up of large fat cells, is producing inflammatory cytokines, and which is metabolically inflexible[4]. Thus, there are both healthy fat and unhealthy fat, with the latter consisting of hypertrophic adipose cells.

Research indicates that Tesamorelin can improve the quality of fat by improving its function. In subjects given Tesamorelin, lipid and triglyceride profiles improved, adipocytes became smaller and more dense, and adiponectin concentrations increased[5]. Thus, Tesamorelin appears to not only reduce fat mass and help with weight loss, but it also helps to improve the function of existing fat tissue and thus improve overall health.

The same studies have not been performed with Ipamorelin, but it seems reasonable to believe that the peptide might have similar effects on fat quality given that both Ipamorelin and Tesamorelin are GH secretagogues. The research remains to be done but will certainly provide valuable insight into the regulation of adipose tissue health and conditions like diabetes and cardiovascular disease that are associated with it.

As a final note, do not take the discussion of fat quality to be any kind of endorsement of the “fit-fat” mentality or the idea that being lean is not desirable. Less is generally more when it comes to fat, although a body fat percentage that is too low can lead to problems. The point is not to say that carrying excess body fat is healthy, that would be a misinterpretation. The point is that lean bodies still carry fat (and should carry fat) and that fat can be either healthy or unhealthy. Future research in this area will likely reveal that fat quality is something that even relatively lean people need to pay attention to and methods for addressing fat quality will likely enhance lifespans and healthspans as well.

Tesamorelin vs Ipamorelin: Muscle Density

It is well known that GH secretagogues can help to build muscle mass and bone mass while reducing fat mass. However, these peptides do not simply increase and decrease the quantity of these tissues. As the section above describes, GH secretagogues also appear to increase the quality of fat tissue. Researchers naturally wondered if they might also affect the quality of other tissues in addition to affecting quantity.

It has long been known that Ipamorelin is of major benefit to bone health. In fact, the peptide has undergone clinical trials to determine its usefulness in the treatment of bone-wasting conditions like osteoporosis and corticosteroid-induced bone loss.

Of course, treatments for bone loss already exist in medications like bisphosphonates, and so it begs the question why reinvent the wheel? As it turns out, while bisphosphonates and existing medications are useful in stopping bone loss and improving bone density, they don't do a whole lot to improve the quality of bone itself. It would be much like shoring up the foundation of a house so that it doesn't continue to sink by doing nothing to address the cracks that are letting in water and making the home unlivable.

As it turns out, Ipamorelin doesn't simply boost bone mineral content and thus make bones denser. Rather, Ipamorelin stimulates the growth and proliferation of the cells responsible for maintaining bone structure and function. The result is that Ipamorelin can increase bone formation in certain settings by as much as 400%, helping increase bone mineral density in a systematic and meaningful way. The result is that bones aren't just denser, they are healthier and more functional. This can help to thwart some of the side effects, such as osteonecrosis of the jaw, associated with existing treatments. Remarkably, Ipamorelin does all of this while being less expensive than existing treatments.

Given the benefit of Ipamorelin on bone quality, scientists wondered if other GH secretagogues might have similar effects but on other tissues. Naturally, they turned to Tesamorelin to test because it already has FDA approval for use in humans. What they found is that Tesamorelin reduces adipose tissue within muscle, vastly increasing muscle density[6]. This may not seem like a big deal, but the deposition of adipose tissue in muscle has been linked to physical function limitations, particularly those associated with age. In fact, increased levels of fat in muscle have even been linked to falls[7].

Similarly, Tesamorelin leads to an increase in the total areas of muscle. These findings suggest that Tesamorelin is increasing overall muscle fiber growth, which is to say that Tesamorelin leads to myofibrillar hypertrophy. Muscle fiber density is directly related to muscle strength as well as muscle stamina and its ability to recover following stress. Muscle density is associated with increased athleticism and is a primary factor in aging. The denser muscles are, the more resilient they are to the ravages of aging.

Tesamorelin vs Ipamorelin: Pain and Inflammation

Previous research has revealed anti-nociceptive (anti-pain) effects of ghrelin mimetics in models of inflammatory, neuropathic, and acute pain. Some of these studies demonstrated that ghrelin mimetics reduced the release of pro-inflammatory cytokines and overall inflammation. In a neuropathic pain model, ghrelin administration in the spinal cord inhibited the activation of signaling pathways associated with pro-inflammatory cytokine upregulation. In an acute pain model, the anti-nociceptive effects of ghrelin were attenuated by an opioid receptor antagonist, suggesting the involvement of the central opioid receptor system in mediating these effects. In short, research has shown that ghrelin mimetics are effective at controlling pain associated with inflammation. To this point, it was thought that the main anti-nociceptive effects of ghrelin mimetics were, in fact, due to their ability to reduce inflammatory signals. New research, however, suggests that this may be only part of the story.

In a new study, a hypersensitivity model was used that did not involve active inflammation. Instead, the researchers induced transient visceral hypersensitivity without active colonic inflammation using a low concentration of acetic acid. In this model, the ghrelin mimetics were able to attenuate both visceral and somatic hypersensitivity. The anti-nociceptive effects were specifically mediated through the ghrelin receptors, as blocking these receptors prevented the improvement of hypersensitivity.

These findings suggest that ghrelin mimetics, like Ipamorelin, have anti-nociceptive properties and can alleviate both visceral and somatic hypersensitivity, even in the absence of active inflammation. The interaction between ghrelin and the ghrelin receptors, as well as the potential involvement of the opioid receptor system, may contribute to the mechanisms underlying these effects. Further research is needed to fully understand the therapeutic potential of ghrelin mimetics in the treatment of pain conditions, but there is a great deal of interest in using these peptides to address abdominal and GI-related pain.

Tesamorelin has not been directly tested for an ability to mitigate pain. Furthermore, as a GHRH mimetic rather than a ghrelin mimetic, the ability of Tesamorelin to influence pain cannot be inferred from the same ability of Ipamorelin. After all, Ipamorelin binds to the ghrelin receptor, and Tesamorelin, as far as we know, does not. Tesamorelin has, however, been associated with the ability to reduce inflammation, albeit modestly. In some studies, Tesamorelin led to a decrease in interconnected proteins associated with cytotoxic T-cell and monocyte activation. Specifically, the circulating concentrations of 13 proteins were significantly reduced by Tesamorelin, while no proteins showed an increase. These proteins included four chemokines (CCL3, CCL4, CCL13 [MCP4], IL8 [CXCL8]), two cytokines (IL-10 and CSF-1), and four T-cell associated molecules (CD8A, CRTAM, GZMA, ADGRG1), as well as ARG1, Gal-9, and HGF. Several of these chemokines are associated with neuropathic pain and may play a role in the propagation of pain neurodegenerative and autoimmune disorders as well as virus-based diseases that have a neuropathic pain component (e.g., herpes zoster/shingles). These findings suggest that Tesamorelin has the ability to modulate immune activation pathways and reduce the levels of specific proteins associated with cytotoxic T-cell and monocyte activation[8]. The down-regulation of these immune pathways may have implications for various types of pain.

Tesamorelin vs Ipamorelin: Research Notes

It might seem that Tesamorelin would be the easier peptide to work with in the research setting. Ipamorelin is not without advantages, though. The peptide is roughly two orders of magnitude cheaper than Tesamorelin, making it very attractive for research on a limited budget. Additionally, Ipamorelin has undergone at least phase II clinical trials and has a very long track record of use in animal research as well. Getting approval for the use of either of these peptides in research should not cause any undue burden.

Tesamorelin vs Ipamorelin: Summary

Tesamorelin and Ipamorelin are more similar than they are different, but their differences are still dramatic. In the Tesamorelin vs Ipamorelin debate, Tesamorelin appears to have a slight advantage in terms of fat loss. It also shows potential for superior cardiovascular properties, although more research is needed to establish this claim conclusively. On the other hand, Ipamorelin demonstrates advantages in improving bone mass and has shown potential benefits in sleep and general cognition. Both peptides are still under investigation for potential therapeutic applications in various disease conditions.

The biggest differences between these two peptides are in their abilities to influence muscle density and pain perception. Tesamorelin appears to be particularly useful at improving muscle density by increasing muscle fiber growth. This makes Tesamorelin of interest in treating muscle wasting and dysfunction associated with aging. Muscle dysfunction is associated with falls and a general decline in physical well-being.

Ipamorelin has been shown to be a highly effective modulator of both inflammatory and non-inflammatory pain. These properties are mediated through action at the ghrelin receptor, and thus it is not immediately clear that Tesamorelin would share any of these pain-relieving benefits. There is interest in using Ipamorelin to explore the treatment of GI pain.

So, more research is needed to fully understand the benefits and limitations of both Tesamorelin and Ipamorelin. What is clear is that the myriad benefits associated with these peptides make them of interest to research circles beyond those dedicated to fat loss. But even where fat loss is concerned, these peptides are helping to open new doors to understanding the role of fat quality in the development of diseases like diabetes. Together, Ipamorelin and Tesamorelin are helping to advance our scientific understanding of the complex control of metabolism, body composition, and energy balance. They have helped to add nuance to existing theories about energy balance and have opened new pathways to understanding the physiology and pathophysiology of adipose tissue. There is a great deal of promise in the future research of both Tesamorelin and Ipamorelin.

Resources

[1] _Clinical Review Report: Tesamorelin (Egrifta)_. in CADTH Common Drug Reviews. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2016. Accessed: Apr. 06, 2022. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK539131/

[2] P. B. Johansen, Y. Segev, D. Landau, M. Phillip, and A. Flyvbjerg, “Growth hormone (GH) hypersecretion and GH receptor resistance in streptozotocin diabetic mice in response to a GH secretagogue,” _Exp. Diabesity Res._, vol. 4, no. 2, pp. 73–81, Jun. 2003, doi: 10.1155/EDR.2003.73.

[3] J. V. Gobburu, H. Agersø, W. J. Jusko, and L. Ynddal, “Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers,” _Pharm. Res._, vol. 16, no. 9, Art. no. 9, Sep. 1999, doi: 10.1023/a:1018955126402.

[4] F. G. De Carvalho, J. N. Justice, E. C. de Freitas, E. E. Kershaw, and L. M. Sparks, “Adipose Tissue Quality in Aging: How Structural and Functional Aspects of Adipose Tissue Impact Skeletal Muscle Quality,” _Nutrients_, vol. 11, no. 11, p. 2553, Oct. 2019, doi: 10.3390/nu11112553.

[5] J. E. Lake _et al._, “Tesamorelin improves fat quality independent of changes in fat quantity,” _AIDS Lond. Engl._, vol. 35, no. 9, pp. 1395–1402, Jul. 2021, doi: 10.1097/QAD.0000000000002897.

[6] S. Adrian _et al._, “The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV,” _J. Frailty Aging_, vol. 8, no. 3, pp. 154–159, 2019, doi: 10.14283/jfa.2018.45.

[7] O. Addison, R. L. Marcus, P. C. Lastayo, and A. S. Ryan, “Intermuscular fat: a review of the consequences and causes,” _Int. J. Endocrinol._, vol. 2014, p. 309570, 2014, doi: 10.1155/2014/309570.

[8] F. A. White, H. Jung, and R. J. Miller, “Chemokines and the pathophysiology of neuropathic pain,” _Proc. Natl. Acad. Sci._, vol. 104, no. 51, pp. 20151–20158, Dec. 2007, doi: 10.1073/pnas.0709250104.

Products available for research use only:

**** ")

[]( "Tesamorelin 5mg ")****

[]( "ipamorelin")

****")

****

Posted in: Ipamorelin Tesamorelin GH Releasers

Be the first to know

Receive all the latest information on events, sales, & offers.

Terms and Conditions of Purchase

Your Use of Our Web Site

Unless specified otherwise, your use of this Web Site is governed by this Terms and Conditions of Use Agreement and the Privacy Policy, which is incorporated herein by this reference. In using this Web Site, you are prohibited from modifying, distributing, transmitting, reproducing, publishing, licensing, transferring, or selling any information, products or services obtained or viewed on this Web Site. However, you may display, download, or print hard copies of any material contained on this Web Site for your own personal, non-commercial use as long as you do not modify the content or delete any copyright, trademark, or other proprietary notice. Any other use of the information contained on this Web Site is prohibited without our express written consent.

All ACH/e-Check payments will be made payable to:

P-Sciences, Inc.

Each time I (the customer) places an ACH/e-Check order by clicking the "Place Order" button, I am authorizing to initiate a single ACH/electronic debit to my account in the amount of my order from the bank account information provided on the date of my order. I agree that ACH transactions I authorize comply with all applicable law. Payments made after 11 P.M. pacific time will be applied as of the next business day. To complete the payment process, click the “Place Order” button. Once payment is authorized, there cannot be any changes or corrections. It is recommended that you print a copy of this authorization and maintain it for your records.

Use of Information

This Web site provides information that, while useful, must not be used as a substitute for the advice of your own advisors. Information available from this Web Site is not intended to be used to diagnose any medical condition or disease. Products on this website are sold for laboratory research purposes only.

reserves the right to correct any inaccuracies or typographical errors in the information posted on this Web Site, and shall have no liability for such errors. Information may be changed or updated without notice and prices and availability of goods and services are subject to change without notice.

DISCLAIMER:

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

The products we offer are intended for IN-VITRO LABORATORY RESEARCH USE ONLY-- NOT FOR HUMAN USE.

In purchasing any of these items, the customer acknowledges that there are risks involved with consumption or distribution of these products.

These chemicals are NOT intended to use as food additives, drugs, household chemicals or other inappropriate applications.

The listing of a material on this site does not constitute a license to its use in infringement of any patent.

All of the products will be handled only by qualified and properly trained RESEARCH or LABORATORY professionals only.

Due to the nature of these products ALL SALES ARE FINAL. WE CANNOT ACCEPT RETURNS. ALL SALES ARE FINAL.

All customers represent and warrant that through their own review and study that they are fully aware and knowledgeable about the following:

Use of the products and more specifically In-vitro Research use of the products.

Your specific countries Government regulations regarding the use of and exposure to all products.

The health and safety hazards associated with the handling of the products they purchase.

The necessity of adequately warning of the health and safety hazards associated with any products.

reserves the right to limit and/or deny sales of products to any unqualified individuals. All customers MUST be at least 21 years of age to purchase our products. IN NO CIRCUMSTANCE SHALL BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, WHETHER PURCHASER'S CLAIM IN CONTRACT, NEGLIGENCE, STRICT LIABILITY OR OTHERWISE. IN DIRECT CONSIDERATION OF APPROVING THE SALE OF ANY PRODUCT TO THE PURCHASER, THE PURCHASER AGREES TO INDEMNIFY AND HOLD US HARMLESS FROM ALL CLAIMS, EXPENSES, LOSSES AND LIABILITY OF ANY TYPE ARISING OUT OF THE PURCHASER'S HANDLING, POSSESSION, AND/OR USE OF THE PRODUCT, WHETHER USED ALONE OR IN COMBINATION WITH ANY SUBSTANCE. ANY SALE WOULD BE DENIED OTHERWISE.

PRODUCT USE:

products are intended for laboratory IN-VITRO RESEARCH PURPOSES ONLY-- NOT FOR HUMAN USE and are not to be used for any other purposes, including but not limited to food and/or drugs, medical devices, vitro diagnostic purpose, or for commercial purposes. The purchaser agrees that the products have not been sterilized or tested by for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. The purchaser expressly represents and warrants to that the purchaser will properly test, use, manufacture and market any products purchased from and/or materials produced with products purchased from in accordance with the practices of a reliable person who is experienced in the field and in strict compliance with all applicable laws and regulations, now and hereinafter enacted. The purchaser further warrants that any material produced with any product shall not be adulterated or misbranded within the meaning of the Federal Food, Drug, and Cosmetic Act and shall not be materials which may not, under Sections 404, 505, or 512 of the Act, be introduced into interstate commerce.

The purchaser realizes that, since products are, unless otherwise stated, intended solely for in-vitro research purposes, they may not be on the Toxic Substances Control Act (TSCA) inventory listing. The purchaser assumes responsibility to assure that the products purchased from are approved for use under TSCA, if applicable.

Purchaser has the responsibility to verify the hazards and to conduct any further research necessary to learn the hazards involved in using products purchased from Purchaser agrees to comply with instructions, if any, furnished by relating to the use of the products and not misuse the products in any manner. No products purchased from shall, unless otherwise stated, be considered to be foods, drugs, or medical devices.

ALL products and services offered are for IN-VITRO RESEARCH purposes ONLY and are NOT TO BE INGESTED or CONSUMED IN ANY MANNER.

ALL PRODUCTS SOLD BY THE ARE NOT TO BE USED FOR PERSONAL USE OR FOR THE TREATMENT OF ANY MEDICAL CONDITION OR DISEASE.

Under NO circumstances shall/ should ANY of these materials be used for recreational purposes nor human consumption of any kind.

is NOT liable for ANY damages that may be caused by negligence, abuse, or ANY other unforeseen matter.

All items sold are legal for sale for IN-VITRO RESEARCH PURPOSES SPECIFICALLY within the USA.

Trade-Marks and Other Intellectual Property Rights

"" is a registered trademark of

All text, graphics, user interfaces, visual interfaces, photographs, trademarks, logos, sounds, music, artwork and computer code (collectively, "Content"), including but not limited to the design, structure, selection, coordination, expression, "look and feel" and arrangement of such Content, contained on this Web Site is owned, controlled or licensed by or to and is protected by copyright, patent and trademark laws, and various other intellectual property rights and unfair competition laws.

Except as expressly provided in this Terms and Conditions of Use Agreement, no part of this Web Site and no Content may be copied, reproduced, republished, uploaded, posted, publicly displayed, encoded, translated, transmitted or distributed in any way (including "mirroring") to any other computer, server, web site or other medium for publication or distribution or for any commercial enterprise, without express prior written consent.

Indemnity

You hereby agree to indemnify and hold and our subsidiaries, affiliates, officers, directors, agents, co-branders, partners, and employees harmless from any claim or demand, including reasonable attorney's fees, made by any third party due to or arising out of your use of the content on this Web Site, or any content you submit, post, or transmit through this Web Site, your use of this Web Site, your connection to this Web site, your violation of this Terms and Conditions of Use Agreement, or your violation of any rights of another.

Links/Software

Links from or to websites outside this Web Site are meant for convenience only. does not review, endorse, approve or control, and is not responsible for any sites linked from or to this Web Site, the content of those sites, the third parties named therein, or their products or services. Linking to any other site is at your sole risk and will not be responsible or liable for any damages in connection with linking. disclaims all warranties, express and implied as to the accuracy, validity and legality of any materials or information found on those sites. Links to downloadable software sites are for convenience only and is not responsible or liable for any difficulties or consequences associated with downloading the software. Use of any downloaded software is governed by the terms of the license agreement, if any, which accompanies or is provided with the software.

Availability of Our Web Site

This Web Site is generally available to users Twenty-four (24) hours per day, Seven (7) days per week, Three Hundred Sixty-five (365) days per year. However, retains the right to make our Web Site unavailable at any time, for any reason, and for any length of time. By using this Web Site you agree that will not be liable for any damage arising out of or related to any such interruption, suspension, or termination of this Web Site and/or the services or products contained therein. Upon acceptance of these terms and conditions of use authorizes you to view the Content on the Web Site solely for your personal use. The material on the Web Site is intended solely for individuals enquiring about products or services. If you are not accessing the Web Site for such purposes, you may not use the Web Site. For certainty, use by non-individuals or the agents, attorneys or representatives of non-individuals is prohibited.

**Information You Provide

Our collection and/or use of any information you provide while using or visiting this Web Site is governed by the Privacy Policy and this Terms and Conditions of Use Agreement. By using this Web Site you grant us the rights contained therein. In using this Web Site you may not upload, distribute, or otherwise publish on this Web Site any information which may be viewed as obscene, defamatory, libelous, threatening, abusive, illegal, an invasion of privacy rights, or otherwise objectionable, or may constitute or encourage a violation of any law.

Except for that individually-identifiable information collected from you in accordance with our Privacy Policy, all comments, remarks, suggestions, ideas or other information communicated will become the exclusive property of and you grant to a royalty-free, perpetual, irrevocable, world-wide, non-exclusive license to use or reproduce the same. is free to copy, disclose, distribute or analyze any such information for any and all purposes and are in no way obligated to compensate you for any such information.

Disclaimer of Warranties

PROVIDES CONTENT ON THIS WEB SITE AS A SERVICE TO YOU, OUR CUSTOMER. THIS WEB SITE CANNOT AND DOES NOT, CONTAIN INFORMATION ABOUT ALL APPLICATIONS FOR PRODUCTS SOLD. IT MAY NOT CONTAIN ALL INFORMATION THAT IS APPLICABLE TO YOUR PERSONAL CIRCUMSTANCES OR YOUR USE OF PRODUCTS SOLD. THE CONTENT OF THIS WEB SITE, THE WEB SITE SERVER THAT MAKES IT AVAILABLE, AND THE SERVICES AND PRODUCTS PROVIDES ON THIS WEB SITE, ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS WITHOUT WARRANTY OF ANY KIND, WHETHER EXPRESS, IMPLIED OR STATUTORY. EXPRESSLY DISCLAIMS LIABILITY FOR TECHNICAL FAILURES (INCLUDING HARDWARE OR SOFTWARE FAILURES), INCOMPLETE, SCRAMBLED OR DELAYED COMPUTER TRANSMISSIONS, AND/OR TECHNICAL INACCURACIES, AS WELL AS UNAUTHORIZED ACCESS OF USER TRANSMISSIONS BY THIRD PARTIES. FURTHER, DOES NOT REPRESENT OR WARRANT THAT NO VIRUSES OR OTHER CONTAMINATING OR DESTRUCTIVE PROPERTIES WILL BE TRANSMITTED, OR THAT NO DAMAGE WILL OCCUR TO YOUR COMPUTER SYSTEM. YOU HAVE SOLE RESPONSIBILITY FOR ADEQUATE PROTECTION AND BACKUP OF DATA AND/OR EQUIPMENT AND TO TAKE ALL PRECAUTIONS TO SCAN FOR COMPUTER VIRUSES OR OTHER DESTRUCTIVE PROPERTIES. BY YOUR USE OF THIS WEB SITE, YOU ACKNOWLEDGE THAT SUCH USE IS AT YOUR SOLE RISK, INCLUDING RESPONSIBILITY FOR ALL COSTS ASSOCIATED WITH ALL NECESSARY SERVICING OR REPAIRS OF ANY EQUIPMENT YOU USE IN CONNECTION WITH THIS WEB SITE.

TO THE FULL EXTENT NOT PRECLUDED BY APPLICABLE LAW THEIR MEDICAL ADVISORS, SUPPLIERS, CONSULTANTS, DIRECTORS AND EMPLOYEES DISCLAIM AND EXCLUDE ALL WARRANTIES WITH RESPECT TO ALL CONTENT, EXPRESS, IMPLIED OR STATUTORY. THIS DISCLAIMER INCLUDES, BUT IS NOT LIMITED TO, ANY AND ALL WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. DOES NOT WARRANT THE CONTENT TO BE ACCURATE, COMPLETE OR CURRENT. DOES NOT WARRANT THAT THIS WEB SITE WILL OPERATE WITHOUT ERROR, THAT DEFECTS WILL BE CORRECTED OR THAT THIS WEB SITE OR THE WEB SITE SERVER MAKING IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. PRICE AND AVAILABILITY CONTENT, AS WELL AS OTHER CONTENT CONTAINED IN THIS WEB SITE OR ACCESSIBLE THEREFROM, IS SUBJECT TO CHANGE WITHOUT NOTICE.

YOU ACKNOWLEDGE AND AGREE THAT DOES NOT ENDORSE THE CONTENT OF ANY SITE ACCESSED VIA LINKS OR OTHER MEANS FROM THIS WEB SITE AND IT IS NOT RESPONSIBLE OR LIABLE FOR SUCH CONTENT EVEN THOUGH IT MAY BE UNLAWFUL, HARASSING, LIBELOUS, PRIVACY INVADING, ABUSIVE, THREATENING, HARMFUL, OBSCENE, OR OTHERWISE OBJECTIONABLE, OR THAT IT INFRINGES OR MAY INFRINGE THE INTELLECTUAL PROPERTY OR OTHER RIGHTS OF ANOTHER PERSON.

THIS WEB SITE INCLUDES CONTENT PROVIDED BY THIRD PARTIES AND YOU, OUR CUSTOMER. IS A DISTRIBUTOR OF SUCH CONTENT AND NOT ITS PUBLISHER. EDITORIAL CONTROL OF SUCH CONTENT IS THE SAME AS THAT OF A PUBLIC LIBRARY OR NEWSSTAND. THIRD PARTY SUPPLIERS MAY EXPRESS CERTAIN OPINIONS OR PROVIDE CERTAIN INFORMATION AND OFFERS. MAKES NO WARRANTIES AS TO THE COMPLETENESS, ACCURACY, TIMELINESS, OR RELIABILITY OF INFORMATION OR OFFERS SUPPLIED BY THIRD PARTIES. DOES NOT GUARANTEE OR WARRANT THE PERFORMANCE OF ANY THIRD PARTY, INCLUDING ANY SUCH THIRD PARTY’S CONFORMANCE TO ANY LAW, RULE, REGULATION OR POLICY.

DOES NOT WARRANT THAT INFORMATION, SERVICES, AND PRODUCTS CONTAINED IN THIS WEB SITE WILL SATISFY YOUR REQUIREMENTS OR THAT THEY ARE ERROR OR DEFECT-FREE. BEFORE USING ANY PRODUCT YOU SHOULD CONFIRM ANY INFORMATION OF IMPORTANCE TO YOU ON THE PRODUCT PACKAGING. YOU ASSUME RESPONSIBILITY FOR THE ACCURACY, APPROPRIATENESS AND LEGALITY OF ANY INFORMATION YOU SUPPLY

AS PARTIAL CONSIDERATION FOR YOUR ACCESS TO THIS WEB SITE AND USE OF ITS CONTENT, YOU AGREE THAT IS NOT LIABLE TO YOU IN ANY MANNER WHATSOEVER FOR DECISIONS YOU MAY MAKE OR YOUR ACTIONS OR NON-ACTIONS IN RELIANCE UPON THE CONTENT. YOU ALSO AGREE THAT THE AGGREGATE LIABILITY OF ARISING FROM OR RELATED TO YOUR USE AND ACCESS REGARDLESS OF THE FORM OF ACTION OR CLAIM (FOR EXAMPLE, CONTRACT, WARRANTY, TORT, NEGLIGENCE, STRICT LIABILITY, PROFESSIONAL MALPRACTICE, FRAUD, OR OTHER BASES FOR CLAIMS), IS LIMITED TO THE PURCHASE PRICE OF ANY ITEMS YOU PURCHASED FROM IN THE APPLICABLE TRANSACTION. SHALL NOT IN ANY CASE BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES EVEN IF HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS IS A COMPREHENSIVE LIMITATION OF LIABILITY THAT APPLIES TO ALL LOSES AND DAMAGES OF ANY KIND. IF YOU ARE DISSATISFIED WITH THIS WEB SITE OR ITS CONTENT (INCLUDING TERMS OF USE), YOUR SOLE EXCLUSIVE REMEDY IS TO DISCONTINUE USING THIS WEB SITE. BECAUSE SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, SUCH LIMITATION MAY NOT BE APPLICABLE TO YOU.

Your Agreement to Abide by All Applicable Laws

By using this Web Site you agree to comply with any and all local, state, or federal laws, statutes, and regulations that relate in any manner to the use of this Web Site and the associated services or products contained thereon.

Relationship between and Users.

and users of our Site are independent contractors, and no agency, partnership, employment or other relationship is created or is intended to be created by the use of our Web Site.

Governing Law and Jurisdiction

This Web Site (excluding linked sites, if any) is administered and controlled by and its affiliates, subsidiaries, officers, directors, employees or agents from its offices in the accordance with the laws of Nevis. You agree that this Terms and Conditions of Use Agreement and this Web Site will be governed by and construed in accordance Nevis law without giving effect to any principles of conflicts of laws. You access this Web Site and/or associated services of at your own risk, and remain responsible for complying with the laws of the jurisdiction within which you are located.

Prices; Payment Terms; Interest

The prices for the products and services on this Web Site are quoted, for convenience, in United States dollars and shall be as set forth in this Web Site as at the time of acceptance of an order by Prices for Products shall be subject to change without any further notice. Credit terms are within sole discretion, and unless otherwise specified in invoice, payment must be received by prior to acceptance of an order.

Consequences

reserves the right to suspend or terminate your account if you violate the Terms of Use Agreement. If your violation causes harm to others, you agree to indemnify and hold harmless from and against any and all loss, damage, or expense. If any dispute arises between us regarding this Agreement or your use of this Web Site, it shall be resolved through good faith negotiations between the parties.

Entire Agreement

These Terms and Conditions and any terms incorporated or referred to herein constitute the entire agreement between and you relating to your use of this Web Site and the subject matter hereof, and supersede any prior understandings or agreements (whether electronic, oral or written) regarding the subject matter, and may not be amended or modified except in writing, or by making such amendments or modifications in accordance with this Terms and Conditions of Use Agreement.

Severability

If any part of this Terms and Conditions of Use Agreement is deemed or determined to be unenforceable, then such part shall be eliminated or limited to the minimum extent necessary. The remainder of this Terms and Conditions of Use Agreement, including any revised portion, shall remain and be in full force and effect. This Terms and Conditions of Use Agreement are the entire agreement between us governing your use of this Web Site.

Headings

The headings contained in this Terms and Conditions of Use Agreement and the Privacy Policy are for reference only.

Force Majeure

shall not be liable for any delay or failure in performance caused by circumstances beyond its reasonable control, including, without limitation, delays due to backorders of requested products, mail delays, customs delays or lost shipments. shall not be responsible to notify the Customer in the event of such delays. The Customer shall be solely responsible to make other arrangements to purchase alternative products and any costs incurred in connection with such purchases.

Thank you again for visiting the Web Site.

Complete Agreement

Except as expressly provided in a particular "legal notice" on this Site, these Terms and Conditions constitute the entire agreement between you and this Site with respect to the use of this Site, and Content. By clicking “I agree” when placing your order, you agree with ALL OF OUR TERMS and CONDITIONS as stated above as well as our Shipping and refunds Policy.

Thank you for your cooperation.

Terms and Conditions of Purchase

Your Use of Our Web Site

Use of Information

DISCLAIMER:

Shipping address will be selected within Apple Pay. Any address entered in checkout will not be used.